Welcome to our dedicated page for Bolt Projects Holdings SEC filings (Ticker: BSLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bolt Projects Holdings, Inc. filings document a biomaterials company focused on beauty and personal care ingredients, its public-company securities, and its corporate-status transition. Recent Forms 25 and 15 cover the removal of the company’s common stock and warrants from Nasdaq listing and registration, along with the certification to terminate or suspend Exchange Act reporting obligations for those securities.
The company’s Form 8-K filings cover operating and financial updates, Regulation FD disclosures, auditor changes, internal-control matters, and going-concern language associated with its financial statements. Proxy and governance filings address shareholder voting mechanics, special meeting matters, bylaw amendments, quorum rules, universal proxy procedures, stockholder nominations, and related capital-structure disclosures for BSLK and BSLKW.
Bolt Projects Holdings, Inc. certified termination of its registration and suspended its duty to file reports under the Securities Exchange Act of 1934 by submitting a Form 15. The filing covers Common Stock, par value $0.0001 per share and warrants described as "each 20 whole warrants exercisable for one share of common stock at an exercise price of $230.00." The certification is signed by Daniel Widmaier, Chief Executive Officer and dated March 12, 2026.